Fmr LLC Bio Xcel Therapeutics, Inc. Transaction History

Fmr LLC

$1.52 Trillion
Q2 2024

A detailed history of Fmr LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 2,205,172 shares of BTAI stock, worth $1.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,205,172

Previous 2,494,116 11.59%

Holding current value

$1.41 Million

Previous $7.03 Million 59.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.14 - $2.97 $329,396 - $858,163	-288,944 Reduced 11.59%	2,205,172 $2.82 Million
Q1 2024 May 13, 2024	SELL	$1.95 - $4.04 $47,673 - $98,769	-24,448 Reduced 0.97%	2,494,116 $7.03 Million
Q4 2023 Feb 13, 2024	SELL	$2.32 - $5.51 $422,618 - $1 Million	-182,163 Reduced 6.74%	2,518,564 $7.43 Million
Q3 2023 Nov 13, 2023	SELL	$2.49 - $11.85 $4.17 Million - $19.8 Million	-1,672,720 Reduced 38.25%	2,700,727 $6.83 Million
Q2 2023 Aug 11, 2023	BUY	$6.39 - $28.58 $618,258 - $2.77 Million	96,754 Added 2.26%	4,373,447 $29.1 Million
Q1 2023 May 11, 2023	BUY	$17.7 - $33.24 $1.3 Million - $2.44 Million	73,257 Added 1.74%	4,276,693 $79.8 Million
Q4 2022 Feb 13, 2023	BUY	$10.25 - $22.43 $59,562 - $130,340	5,811 Added 0.14%	4,203,436 $90.3 Million
Q3 2022 Nov 10, 2022	BUY	$11.19 - $17.89 $3,010 - $4,812	269 Added 0.01%	4,197,625 $49.6 Million
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $288 - $689	32 Added 0.0%	4,197,356 $55.4 Million
Q1 2022 May 13, 2022	BUY	$15.0 - $22.83 $4,125 - $6,278	275 Added 0.01%	4,197,324 $87.8 Million
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $8.28 Million - $14.4 Million	411,665 Added 10.88%	4,197,049 $85.3 Million
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $16 Million - $21.5 Million	670,571 Added 21.53%	3,785,384 $115 Million
Q2 2021 Aug 13, 2021	BUY	$29.06 - $38.83 $90.5 Million - $121 Million	3,114,813 New	3,114,813 $90.5 Million

Others Institutions Holding BTAI

# of Institutions

Shares Held

7.2M

Call Options Held

101K

Put Options Held

205K

View Full List

About BioXcel Therapeutics, Inc.

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $17.9M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

More about BTAI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account